NRC Files 8-K on Officer/Director Changes, Compensation
Ticker: NRC · Form: 8-K · Filed: Jan 2, 2024 · CIK: 70487
| Field | Detail |
|---|---|
| Company | National Research CORP (NRC) |
| Form Type | 8-K |
| Filed Date | Jan 2, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: corporate-governance, executive-changes, compensation
TL;DR
**NRC filed an 8-K about executive changes and pay, keep an eye on leadership shifts.**
AI Summary
National Research Corporation (NRC) filed an 8-K on January 2, 2024, reporting an event that occurred on December 28, 2023. This filing is a standard disclosure regarding changes in directors, officers, or their compensation arrangements. For investors, this matters because changes in leadership or executive pay can signal shifts in company strategy, financial health, or governance, potentially impacting future stock performance.
Why It Matters
This filing indicates potential changes in leadership or executive compensation at National Research Corporation, which can influence investor confidence and the company's strategic direction.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of corporate governance changes, not indicating immediate financial distress or major operational risks.
Analyst Insight
A smart investor would monitor subsequent filings or company announcements for specific details regarding the personnel changes or compensation adjustments mentioned in this 8-K, as these specifics could impact future company performance and stock valuation.
Key Players & Entities
- National Research Corporation (company) — the registrant filing the 8-K
- December 28, 2023 (date) — date of the earliest event reported
- January 2, 2024 (date) — date the 8-K was filed
- 001-35929 (other) — Commission File Number
- NRC (other) — Trading Symbol for Common Stock
- The NASDAQ Stock Market (other) — exchange where NRC common stock is registered
FAQ
What is the purpose of this 8-K filing by National Research Corporation?
This 8-K filing by National Research Corporation is a 'Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934' and specifically falls under 'ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers'.
When did the earliest event reported in this 8-K occur?
The earliest event reported in this 8-K occurred on December 28, 2023, as stated under 'Date of Report (Date of earliest event reported): December 28, 2023'.
What is the trading symbol and exchange for National Research Corporation's common stock?
National Research Corporation's common stock has the trading symbol 'NRC' and is registered on 'The NASDAQ Stock Market', as indicated in the 'Securities registered pursuant to Section 12(b) of the Act' section.
Is National Research Corporation considered an emerging growth company?
No, National Research Corporation is not considered an emerging growth company, as indicated by the unchecked box next to 'Emerging growth company' in the filing.
What is the state of incorporation for National Research Corporation?
National Research Corporation's state of incorporation is Delaware, as stated in the filing under 'Delaware (State or other jurisdiction of incorporation)'.
Filing Stats: 470 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-01-02 14:51:11
Filing Documents
- nrc20240102_8k.htm (8-K) — 22KB
- 0001437749-24-000174.txt ( ) — 149KB
- nrc-20231228.xsd (EX-101.SCH) — 3KB
- nrc-20231228_def.xml (EX-101.DEF) — 11KB
- nrc-20231228_lab.xml (EX-101.LAB) — 15KB
- nrc-20231228_pre.xml (EX-101.PRE) — 11KB
- nrc20240102_8k_htm.xml (XML) — 2KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.       On December 28, 2023, Jona S. Raasch gave notice that she would no longer serve in the role of Chief Operating Officer of National Research Corporation, a Delaware corporation (the "Company"), effective December 31, 2023. Ms. Raasch will continue to serve in other roles as an employee of the Company. The Company thanks Ms. Raasch for over 30 years of dedicated leadership.         SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.     NATIONAL RESEARCH CORPORATION   (Registrant)         Date: January 2, 2024 By: /s/ Kevin R. Karas     Kevin R. Karas     Senior Vice President Finance, Chief Financial Officer, Treasurer and Secretary